<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BMC Biochemistry - Latest articles</title>
		<link>http://www.biomedcentral.com/bmcbiochem/</link>
		<description>The latest articles from BMC Biochemistry (ISSN 1471-2091) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/9/13"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/9/12"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/9/11"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/9/10"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/9/9"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/9/8"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/9/7"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/9/6"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/9/5"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/9/4"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2091/9/3"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.biomedcentral.com/1471-2091/9/13">
            
            <title>The Mycobacterium tuberculosis Rv2540c DNA sequence encodes a bifunctional chorismate synthase</title>
			<description>Background:
The emergence of multi- and extensively-drug resistant Mycobacterium tuberculosis strains has created an urgent need for new agents to treat tuberculosis (TB). The enzymes of shikimate pathway are attractive targets to the development of antitubercular agents because it is essential for M. tuberculosis and is absent from humans. Chorismate synthase (CS) is the seventh enzyme of this route and catalyzes the NADH- and FMN-dependent synthesis of chorismate, a precursor of aromatic amino acids, naphthoquinones, menaquinones, and mycobactins. Although the M. tuberculosis Rv2540c (aroF) sequence has been annotated to encode a chorismate synthase, there has been no report on its correct assignment and functional characterization of its protein product.
Results:
In the present work, we describe DNA amplification of aroF-encoded CS from M. tuberculosis (MtCS), molecular cloning, protein expression, and purification to homogeneity. N-terminal amino acid sequencing, mass spectrometry and gel filtration chromatography were employed to determine identity, subunit molecular weight and oligomeric state in solution of homogeneous recombinant MtCS. The bifunctionality of MtCS was determined by measurements of both chorismate synthase and NADH:FMN oxidoreductase activities. The flavin reductase activity was characterized, showing the existence of a complex between FMNox and MtCS. FMNox and NADH equilibrium binding was measured. Primary deuterium, solvent and multiple kinetic isotope effects are described and suggest distinct steps for hydride and proton transfers, with the former being more rate-limiting.
Conclusion:
This is the first report showing that a bacterial CS is bifunctional. Primary deuterium kinetic isotope effects show that C4-proS hydrogen is being transferred during the reduction of FMNox by NADH and that hydride transfer contributes significantly to the rate-limiting step of FMN reduction reaction. Solvent kinetic isotope effects and proton inventory results indicate that proton transfer from solvent partially limits the rate of FMN reduction and that a single proton transfer gives rise to the observed solvent isotope effect. Multiple isotope effects suggest a stepwise mechanism for the reduction of FMNox. The results on enzyme kinetics described here provide evidence for the mode of action of MtCS and should thus pave the way for the rational design of antitubercular agents.</description>
			<link>http://www.biomedcentral.com/1471-2091/9/13</link>
			
			 	<dc:creator>Fernanda Ely, Jos&#233; ES Nunes, Evelyn K Schroeder, Jeverson Frazzon, M&#225;rio S Palma, Di&#243;genes S Santos and Luiz A Basso</dc:creator>
			
			<dc:source>BMC Biochemistry 2008, 9:13</dc:source>
			<dc:date>2008-04-29</dc:date>
			<dc:identifier>doi:10.1186/1471-2091-9-13</dc:identifier>
			
			
							
					<prism:publicationName>BMC Biochemistry</prism:publicationName>
					
			
							
					<prism:issn>1471-2091</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>13</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2091/9/12">
            
            <title>Regulation of 5'-adenosine monophosphate deaminase in the freeze tolerant wood frog, Rana sylvatica</title>
			<description>Background:
The wood frog, Rana sylvatica, is one of a few vertebrate species that have developed natural freeze tolerance, surviving days or weeks with 65&#8211;70% of its total body water frozen in extracellular ice masses. Frozen frogs exhibit no vital signs and their organs must endure multiple stresses, particularly long term anoxia and ischemia. Maintenance of cellular energy supply is critical to viability in the frozen state and in skeletal muscle, AMP deaminase (AMPD) plays a key role in stabilizing cellular energetics. The present study investigated AMPD control in wood frog muscle.
Results:
Wood frog AMPD was subject to multiple regulatory controls: binding to subcellular structures, protein phosphorylation, and effects of allosteric effectors, cryoprotectants and temperature. The percentage of bound AMPD activity increased from 20 to 35% with the transition to the frozen state. Bound AMPD showed altered kinetic parameters compared with the free enzyme (S0.5 AMP was reduced, Hill coefficient fell to ~1.0) and the transition to the frozen state led to a 3-fold increase in S0.5 AMP of the bound enzyme. AMPD was a target of protein phosphorylation. Bound AMPD from control frogs proved to be a low phosphate form with a low S0.5 AMP and was phosphorylated in incubations that stimulated PKA, PKC, CaMK, or AMPK. Bound AMPD from frozen frogs was a high phosphate form with a high S0.5 AMP that was reduced under incubation conditions that stimulated protein phosphatases. Frog muscle AMPD was activated by Mg&#183;ATP and Mg&#183;ADP and inhibited by Mg&#183;GTP, KCl, NaCl and NH4Cl. The enzyme product, IMP, uniquely inhibited only the bound (phosphorylated) enzyme from muscle of frozen frogs. Activators and inhibitors differentially affected the free versus bound enzyme. S0.5 AMP of bound AMPD was also differentially affected by high versus low assay temperature (25 vs 5&#176;C) and by the presence/absence of the natural cryoprotectant (250 mM glucose) that accumulates during freezing.
Conclusion:
Maintenance of long term viability under the ischemic conditions in frozen muscle requires attention to the control of cellular energetics. Differential regulatory controls on AMPD by mechanisms including binding to muscle proteins, actions allosteric effectors, glucose and temperature effects and reversible phosphorylation adjust enzyme function for an optimal role in controlling cellular adenylate levels in ischemic frozen muscle. Stable modification of AMPD properties via freeze-responsive phosphorylation may contribute both to AMPD control and to coordinating AMPD function with other enzymes of energy metabolism in cold ischemic muscle.</description>
			<link>http://www.biomedcentral.com/1471-2091/9/12</link>
			
			 	<dc:creator>Christopher A Dieni and Kenneth B Storey</dc:creator>
			
			<dc:source>BMC Biochemistry 2008, 9:12</dc:source>
			<dc:date>2008-04-22</dc:date>
			<dc:identifier>doi:10.1186/1471-2091-9-12</dc:identifier>
			
			
							
					<prism:publicationName>BMC Biochemistry</prism:publicationName>
					
			
							
					<prism:issn>1471-2091</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>12</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2091/9/11">
            
            <title>A new classification system for bacterial Rieske non-heme iron aromatic ring-hydroxylating oxygenases</title>
			<description>Background:
Rieske non-heme iron aromatic ring-hydroxylating oxygenases (RHOs) are multi-component enzyme systems that are remarkably diverse in bacteria isolated from diverse habitats. Since the first classification in 1990, there has been a need to devise a new classification scheme for these enzymes because many RHOs have been discovered, which do not belong to any group in the previous classification. Here, we present a scheme for classification of RHOs reflecting new sequence information and interactions between RHO enzyme components.ResultWe have analyzed a total of 130 RHO enzymes in which 25 well-characterized RHO enzymes were used as standards to test our hypothesis for the proposed classification system. From the sequence analysis of electron transport chain (ETC) components of the standard RHOs, we extracted classification keys that reflect not only the phylogenetic affiliation within each component but also relationship among components. Oxygenase components of standard RHOs were phylogenetically classified into 10 groups with the classification keys derived from ETC components. This phylogenetic classification scheme was converted to a new systematic classification consisting of 5 distinct types. The new classification system was statistically examined to justify its stability. Type I represents two-component RHO systems that consist of an oxygenase and an FNRC-type reductase. Type II contains other two-component RHO systems that consist of an oxygenase and an FNRN-type reductase. Type III represents a group of three-component RHO systems that consist of an oxygenase, a [2Fe-2S]-type ferredoxin and an FNRN-type reductase. Type IV represents another three-component systems that consist of oxygenase, [2Fe-2S]-type ferredoxin and GR-type reductase. Type V represents another different three-component systems that consist of an oxygenase, a [3Fe-4S]-type ferredoxin and a GR-type reductase.
Conclusion:
The new classification system provides the following features. First, the new classification system analyzes RHO enzymes as a whole. RwithSecond, the new classification system is not static but responds dynamically to the growing pool of RHO enzymes. Third, our classification can be applied reliably to the classification of incomplete RHOs. Fourth, the classification has direct applicability to experimental work. Fifth, the system provides new insights into the evolution of RHO systems based on enzyme interaction.</description>
			<link>http://www.biomedcentral.com/1471-2091/9/11</link>
			
			 	<dc:creator>Ohgew Kweon, Seong-Jae Kim, Songjoon Baek, Jong-Chan Chae, Michael D Adjei, Dong-Heon Baek, Young-Chang Kim and Carl E Cerniglia</dc:creator>
			
			<dc:source>BMC Biochemistry 2008, 9:11</dc:source>
			<dc:date>2008-04-03</dc:date>
			<dc:identifier>doi:10.1186/1471-2091-9-11</dc:identifier>
			
			
							
					<prism:publicationName>BMC Biochemistry</prism:publicationName>
					
			
							
					<prism:issn>1471-2091</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>11</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-03</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2091/9/10">
            
            <title>Characterization and site-directed mutagenesis of Wzb, an O-phosphatase from Lactobacillus rhamnosus</title>
			<description>Background:
Reversible phosphorylation events within a polymerisation complex have been proposed to modulate capsular polysaccharide synthesis in Streptococcus pneumoniae. Similar phosphatase and kinase genes are present in the exopolysaccharide (EPS) biosynthesis loci of numerous lactic acid bacteria genomes.
Results:
The protein sequence deduced from the wzb gene in Lactobacillus rhamnosus ATCC 9595 reveals four motifs of the polymerase and histidinol phosphatase (PHP) superfamily of prokaryotic O-phosphatases. Native and modified His-tag fusion Wzb proteins were purified from Escherichia coli cultures. Extracts showed phosphatase activity towards tyrosine-containing peptides. The purified fusion protein Wzb was active on p-nitrophenyl-phosphate (pNPP), with an optimal activity in presence of bovine serum albumin (BSA 1%) at pH 7.3 and a temperature of 75&#176;C. At 50&#176;C, residual activity decreased to 10 %. Copper ions were essential for phosphatase activity, which was significantly increased by addition of cobalt. Mutated fusion Wzb proteins exhibited reduced phosphatase activity on p-nitrophenyl-phosphate. However, one variant (C6S) showed close to 20% increase in phosphatase activity.
Conclusion:
These characteristics reveal significant differences with the manganese-dependent CpsB protein tyrosine phosphatase described for Streptococcus pneumoniae as well as with the polysaccharide-related phosphatases of Gram negative bacteria.</description>
			<link>http://www.biomedcentral.com/1471-2091/9/10</link>
			
			 	<dc:creator>Gis&#232;le LaPointe, Dani&#232;le Atlan and Christophe Gilbert</dc:creator>
			
			<dc:source>BMC Biochemistry 2008, 9:10</dc:source>
			<dc:date>2008-04-03</dc:date>
			<dc:identifier>doi:10.1186/1471-2091-9-10</dc:identifier>
			
			
							
					<prism:publicationName>BMC Biochemistry</prism:publicationName>
					
			
							
					<prism:issn>1471-2091</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>10</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-03</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2091/9/9">
            
            <title>Pro-protein convertases control the maturation and processing of the iron-regulatory protein, RGMc/hemojuvelin</title>
			<description>Background:
Repulsive guidance molecule c (RGMc or hemojuvelin), a glycosylphosphatidylinositol-linked glycoprotein expressed in liver and striated muscle, plays a central role in systemic iron balance. Inactivating mutations in the RGMc gene cause juvenile hemochromatosis (JH), a rapidly progressing iron storage disorder with severe systemic manifestations. RGMc undergoes complex biosynthetic steps leading to membrane-bound and soluble forms of the protein, including both 50 and 40 kDa single-chain species.
Results:
We now show that pro-protein convertases (PC) are responsible for conversion of 50 kDa RGMc to a 40 kDa protein with a truncated COOH-terminus. Unlike related molecules RGMa and RGMb, RGMc encodes a conserved PC recognition and cleavage site, and JH-associated RGMc frame-shift mutants undergo COOH-terminal cleavage only if this site is present. A cell-impermeable peptide PC inhibitor blocks the appearance of 40 kDa RGMc in extra-cellular fluid, as does an engineered mutation in the conserved PC recognition sequence, while the PC furin cleaves 50 kDa RGMc in vitro into a 40 kDa molecule with an intact NH2-terminus. Iron loading reduces release of RGMc from the cell membrane, and diminishes accumulation of the 40 kDa species in cell culture medium.
Conclusion:
Our results define a role for PCs in the maturation of RGMc that may have implications for the physiological actions of this critical iron-regulatory protein.</description>
			<link>http://www.biomedcentral.com/1471-2091/9/9</link>
			
			 	<dc:creator>David Kuninger, Robin Kuns-Hashimoto, Mahta Nili and Peter Rotwein</dc:creator>
			
			<dc:source>BMC Biochemistry 2008, 9:9</dc:source>
			<dc:date>2008-04-02</dc:date>
			<dc:identifier>doi:10.1186/1471-2091-9-9</dc:identifier>
			
			
							
					<prism:publicationName>BMC Biochemistry</prism:publicationName>
					
			
							
					<prism:issn>1471-2091</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>9</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-02</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2091/9/8">
            
            <title>The pyrroloquinoline quinone biosynthesis pathway revisited: A structural approach</title>
			<description>Background:
The biosynthesis pathway of Pyrroloquinoline quinone, a bacterial redox active cofactor for numerous alcohol and aldose dehydrogenases, is largely unknown, but it is proven that at least six genes in Klebsiella pneumoniae (PqqA-F) are required, all of which are located in the PQQ-operon.
Results:
New structural data of some PQQ biosynthesis proteins and their homologues provide new insights and functional assignments of the proteins in the pathway. Based on sequence analysis and homology models we propose the role and catalytic function for each enzyme involved in this intriguing biosynthesis pathway.
Conclusion:
PQQ is derived from the two amino acids glutamate and tyrosine encoded in the precursor peptide PqqA. Five reactions are necessary to form this quinone cofactor. The PqqA peptide is recognised by PqqE, which links the C9 and C9a, afterwards it is accepted by PqqF which cuts out the linked amino acids. The next reaction (Schiff base) is spontaneous, the following dioxygenation is catalysed by an unknown enzyme. The last cyclization and oxidation steps are catalysed by PqqC. Taken together the known facts of the different proteins we assign a putative function to all six proteins in PQQ biosynthesis pathway.</description>
			<link>http://www.biomedcentral.com/1471-2091/9/8</link>
			
			 	<dc:creator>Sandra Puehringer, Moritz Metlitzky and Robert Schwarzenbacher</dc:creator>
			
			<dc:source>BMC Biochemistry 2008, 9:8</dc:source>
			<dc:date>2008-03-27</dc:date>
			<dc:identifier>doi:10.1186/1471-2091-9-8</dc:identifier>
			
			
							
					<prism:publicationName>BMC Biochemistry</prism:publicationName>
					
			
							
					<prism:issn>1471-2091</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>8</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-27</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2091/9/7">
            
            <title>Prion protein insertional mutations increase aggregation propensity but not fiber stability</title>
			<description>Background:
Mutations in the PRNP gene account for ~15% of all prion disease cases. Little is understood about the mechanism of how some of these mutations in PRNP cause the protein to aggregate into amyloid fibers or cause disease. We have taken advantage of a chimeric protein system to study the oligopeptide repeat domain (ORD) expansions of the prion protein, PrP, and their effect on protein aggregation and amyloid fiber formation. We replaced the ORD of the yeast prion protein Sup35p with that from wild type and expanded ORDs of PrP and compared their biochemical properties in vitro. We previously determined that these chimeric proteins maintain the [PSI+] yeast prion phenotype in vivo. Interestingly, we noted that the repeat expanded chimeric prions seemed to be able to maintain a stronger strain of [PSI+] and convert from [psi-] to [PSI+] with a much higher frequency. In this study we have attempted to understand the biochemical properties of these chimeric proteins and to establish a system to study the properties of the ORD of PrP both in vivo and in vitro.
Results:
Investigation of the chimeric proteins in vitro reveals that repeat-expansions increase aggregation propensity and that the kinetics of fiber formation depends on the number of repeats. The fiber formation reactions are promiscuous in that the chimeric protein containing 14 repeats can readily cross-seed fiber formation of proteins that have the wild type number of repeats. Morphologically, the amyloid fibers formed by repeat-expanded proteins associate with each other to form large clumps that were not as prevalent in fibers formed by proteins containing the wild type number of repeats. Despite the increased aggregation propensity and lateral association of the repeat expanded proteins, there was no corresponding increase in the stability of the fibers formed. Therefore, we predict that the differences in fibers formed with different repeat lengths may not be due to gross changes in the amyloid core.
Conclusion:
The biochemical observations presented here explain the properties of these chimeric proteins previously observed in yeast. More importantly, they suggest a mechanism for the observed correlation between age of onset and disease severity with respect to the length of the ORD in humans.</description>
			<link>http://www.biomedcentral.com/1471-2091/9/7</link>
			
			 	<dc:creator>Tejas Kalastavadi and Heather L True</dc:creator>
			
			<dc:source>BMC Biochemistry 2008, 9:7</dc:source>
			<dc:date>2008-03-17</dc:date>
			<dc:identifier>doi:10.1186/1471-2091-9-7</dc:identifier>
			
			
							
					<prism:publicationName>BMC Biochemistry</prism:publicationName>
					
			
							
					<prism:issn>1471-2091</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>7</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-17</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2091/9/6">
            
            <title>Functional role of the additional domains in inulosucrase (IslA) from Leuconostoc citreum CW28</title>
			<description>Background:
Inulosucrase (IslA) from Leuconostoc citreum CW28 belongs to a new subfamily of multidomain fructosyltransferases (FTFs), containing additional domains from glucosyltransferases. It is not known what the function of the additional domains in this subfamily is.
Results:
Through construction of truncated versions we demonstrate that the acquired regions are involved in anchoring IslA to the cell wall; they also confer stability to the enzyme, generating a larger structure that affects its kinetic properties and reaction specificity, particularly the hydrolysis and transglycosylase ratio. The accessibility of larger molecules such as EDTA to the catalytic domain (where a Ca2+ binding site is located) is also affected as demonstrated by the requirement of 100 times higher EDTA concentrations to inactivate IslA with respect to the smallest truncated form.
Conclusion:
The C-terminal domain may have been acquired to anchor inulosucrase to the cell surface. Furthermore, the acquired domains in IslA interact with the catalytic core resulting in a new conformation that renders the enzyme more stable and switch the specificity from a hydrolytic to a transglycosylase mechanism. Based on these results, chimeric constructions may become a strategy to stabilize and modulate biocatalysts based on FTF activity.</description>
			<link>http://www.biomedcentral.com/1471-2091/9/6</link>
			
			 	<dc:creator>Sandra del Moral, Clarita Olvera, Maria Elena Rodriguez and Agustin Lopez Munguia</dc:creator>
			
			<dc:source>BMC Biochemistry 2008, 9:6</dc:source>
			<dc:date>2008-01-31</dc:date>
			<dc:identifier>doi:10.1186/1471-2091-9-6</dc:identifier>
			
			
							
					<prism:publicationName>BMC Biochemistry</prism:publicationName>
					
			
							
					<prism:issn>1471-2091</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>6</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-01-31</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2091/9/5">
            
            <title>Thermal dependency of RAG1 self-association properties</title>
			<description>Background:
Functional immunoglobulin and T cell receptor genes are produced in developing lymphocytes by V(D)J recombination. The initial site-specific DNA cleavage steps in this process are catalyzed by the V(D)J recombinase, consisting of RAG1 and RAG2, which is directed to appropriate DNA cleavage sites by recognition of the conserved recombination signal sequence (RSS). RAG1 contains both the active site and the RSS binding domains, although RAG2 is also required for DNA cleavage activity. An understanding of the physicochemical properties of the RAG proteins, their association, and their interaction with the RSS is not yet well developed.
Results:
Here, we further our investigations into the self-association properties of RAG1 by demonstrating that despite the presence of multiple RAG1 oligomers, only the dimeric form maintains the ability to interact with RAG2 and the RSS. However, facile aggregation of the dimeric form at physiological temperature may render this protein inactive in the absence of RAG2. Upon addition of RAG2 at 37&#176;C, the preferentially stabilized V(D)J recombinase:RSS complex contains a single dimer of RAG1.
Conclusion:
Together these results confirm that the functional form of RAG1 in V(D)J recombination is in the dimeric state, and that its stability under physiological conditions likely requires complex formation with RAG2. Additionally, in future structural and functional studies of RAG1, it will be important to take into account the temperature-dependent self-association properties of RAG1 described in this study.</description>
			<link>http://www.biomedcentral.com/1471-2091/9/5</link>
			
			 	<dc:creator>Pallabi De, Shuying Zhao, Lori M Gwyn, LeAnn J Godderz, Mandy M Peak and Karla K Rodgers</dc:creator>
			
			<dc:source>BMC Biochemistry 2008, 9:5</dc:source>
			<dc:date>2008-01-30</dc:date>
			<dc:identifier>doi:10.1186/1471-2091-9-5</dc:identifier>
			
			
							
					<prism:publicationName>BMC Biochemistry</prism:publicationName>
					
			
							
					<prism:issn>1471-2091</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>5</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-01-30</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2091/9/4">
            
            <title>Components of the ubiquitin-proteasome pathway compete for surfaces on Rad23 family proteins</title>
			<description>Background:
The delivery of ubiquitinated proteins to the proteasome for degradation is a key step in the regulation of the ubiquitin-proteasome pathway, yet the mechanisms underlying this step are not understood in detail. The Rad23 family of proteins is known to bind ubiquitinated proteins through its two ubiquitin-associated (UBA) domains, and may participate in the delivery of ubiquitinated proteins to the proteasome through docking via the Rad23 ubiquitin-like (UBL) domain.
Results:
In this study, we investigate how the interaction between the UBL and UBA domains may modulate ubiquitin recognition and the delivery of ubiquitinated proteins to the proteasome by autoinhibition. We have explored a competitive binding model using specific mutations in the UBL domain. Disrupting the intramolecular UBL-UBA domain interactions in HHR23A indeed potentiates ubiquitin-binding. Additionally, the analogous surface on the Rad23 UBL domain overlaps with that required for interaction with both proteasomes and the ubiquitin ligase Ufd2. We have found that mutation of residues on this surface affects the ability of Rad23 to deliver ubiquitinated proteins to the proteasome.
Conclusion:
We conclude that the competition of ubiquitin-proteasome pathway components for surfaces on Rad23 is important for the role of the Rad23 family proteins in proteasomal targeting.</description>
			<link>http://www.biomedcentral.com/1471-2091/9/4</link>
			
			 	<dc:creator>Amanda M Goh, Kylie J Walters, Suzanne Elsasser, Rati Verma, Raymond J Deshaies, Daniel Finley and Peter M Howley</dc:creator>
			
			<dc:source>BMC Biochemistry 2008, 9:4</dc:source>
			<dc:date>2008-01-30</dc:date>
			<dc:identifier>doi:10.1186/1471-2091-9-4</dc:identifier>
			
			
							
					<prism:publicationName>BMC Biochemistry</prism:publicationName>
					
			
							
					<prism:issn>1471-2091</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>4</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-01-30</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2091/9/3">
            
            <title>Blocking binding of Bacillus thuringiensis Cry1Aa to Bombyx mori cadherin receptor results in only a minor reduction of toxicity</title>
			<description>Background:
Bacillus thuringiensis Cry1Aa insecticidal protein is the most active known B. thuringiensis toxin against the forest insect pest Lymantria dispar (gypsy moth), unfortunately it is also highly toxic against the non-target insect Bombyx mori (silk worm).
Results:
Surface exposed hydrophobic residues over domains II and III were targeted for site-directed mutagenesis. Substitution of a phenylalanine residue (F328) by alanine reduced binding to the Bombyx mori cadherin by 23-fold, reduced biological activity against B. mori by 4-fold, while retaining activity against Lymantria dispar.
Conclusion:
The results identify a novel receptor-binding epitope and demonstrate that virtual elimination of binding to cadherin BR-175 does not completely remove toxicity in the case of B. mori.</description>
			<link>http://www.biomedcentral.com/1471-2091/9/3</link>
			
			 	<dc:creator>Taek H You, Mi K Lee, Jeremy L Jenkins, Oscar Alzate and Donald H Dean</dc:creator>
			
			<dc:source>BMC Biochemistry 2008, 9:3</dc:source>
			<dc:date>2008-01-24</dc:date>
			<dc:identifier>doi:10.1186/1471-2091-9-3</dc:identifier>
			
			
							
					<prism:publicationName>BMC Biochemistry</prism:publicationName>
					
			
							
					<prism:issn>1471-2091</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>3</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-01-24</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
